April 6, 2021
Link to Printer Friendly Version in PDF Format (11 PDF pages)
Medicare
Reports
Displaying 41 - 50 of 187. 10 per page. Page 5.
Advanced SearchRisk of COVID-19 Infections, Hospitalization, and Death in Fee-For-Service Medicare
Experience during the first six months of the pandemic shows that the risks of Medicare fee-for-service (FFS) beneficiaries contracting COVID-19 and subsequent hospitalization and mortality vary significantly by demographic characteristics, health status, and nursing home residence. There are several factors that indicate significantly elevated risk.
ASPE Issue Brief
Medicare Part D: Competition and Generic Drug Prices, 2007-2018
The United States relies on the interactions of private entities – drug manufacturers, health plans and pharmaceutical benefit managers (PBMs) - to achieve value by negotiating prices, operating formularies and implementing other benefit management strategies. The U.S. does not establish or negotiate prices for prescription drugs, as do some other countries. A critical part of the U.S.
Medicare: Opportunities for Market-Based Policies
Market-based payment policies such as competitive bidding, reference pricing, centers of excellence and tiered provider networks have been implemented both in Medicare and across the private sector, as described in this report required by Executive Order 13890.
Medicare FFS Part B and International Drug Prices: A Comparison of the Top 50 Drugs
The September 13, 2020 Executive Order on Lowering Drug Prices by Putting America First declared, “It is the policy of the United States that the Medicare program should not pay more for costly Part B or Part D prescription drugs or biological products than the most-favored-nation price.” The Most Favored Nation (MFN) Model issued by the Centers for Medicare & Medicaid Services (CMS) on No
Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016
CHANGES IN HOME HEALTH CARE USE IN MEDICARE ADVANTAGE COMPARED TO TRADITIONAL MEDICARE, 2011-2016
Stephen Zuckerman, Laura Skopec, Joshua Aarons, Robert A. Berenson, Judith Feder, and Douglas Wissoker
Urban Institute
Peter J. Huckfeldt
ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT
ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT Fang He, PhD, Angela Gasdaska, BS, Hannah Friedman, BA, Brendan Wedehas, BS, Alexis Kirk, PhD, Ila Broyles, PhD, and SaritaL.
Research Brief
Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief
Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief Fang He, PhD; Angela Gasdaska, BS; Hannah Friedman, BA; Brendan Wedehase, BS; Alexis Kirk, PhD; Ila Broyles, PhD; Sarita L.
ASPE Issue Brief
The Impact of COVID-19 on Medicare Health Services and Payments
Beginning in mid-March 2020, the COVID-19 pandemic has had an unprecedented impact on health care utilization. The impact on patients, their families and the health care system was significant.
Report to Congress
Second Report to Congress on Social Risk and Medicare's Value-Based Purchasing Programs
As required by the IMPACT Act, the second Report to Congress examines the effect of individuals’ social risk factors on quality measures, resource use, and other measures under the Medicare program, as well as analyses of the effects of Medicare’s current value-based payment programs on providers serving socially at-risk beneficiaries and simulations of potential policy options to address these